Literature DB >> 5451577

The serum paraprotein level related to the number of plasmacytoma-5536 cells in C3H mice.

O Fakhri, J R Hobbs.   

Abstract

An ascitic form of plasmacytoma (MP-5563) in C3H mice has proved stable on transplantation. A simple linear relationship was demonstrated between the serum level of the paraprotein produced and the total number of plasmacytoma cells within the ascitic fluid.

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5451577      PMCID： PMC2008573          DOI： 10.1038/bjc.1970.46

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  5 in total

1.  A TRANSPLANTABLE PLASMA CELL TUMOUR IN THE STUDY OF CARCINOSTATIC AGENTS.

Authors:  V M ROSENOER; M E WHISSON
Journal:  Biochem Pharmacol       Date:  1964-04       Impact factor: 5.858

2.  STUDIES OF MORPHOGENESIS AND PROTEIN SYNTHESIS IN THREE MOUSE PLASMA CELL TUMORS (X5563, ADJ. PC-6C, AND ADJ. PC-20).

Authors:  E F OSSERMAN; R A RIFKIND; K TAKATSUKI; D P LAWLOR
Journal:  Ann N Y Acad Sci       Date:  1964-02-28       Impact factor: 5.691

3.  A staining method for proteins and dextrans on cellulose acetate.

Authors:  J R Hobbs
Journal:  Nature       Date:  1965-07-17       Impact factor: 49.962

4.  The formation of myeloma protein by a mouse plasma cell tumor.

Authors:  D NATHANS; J L FAHEY; M POTTER
Journal:  J Exp Med       Date:  1958-07-01       Impact factor: 14.307

5.  The growth characteristics of an ascitic plasmacytoma (MP 5563) terminating by fistulous communication with the blood-stream.

Authors:  O Fakhri
Journal:  Br J Cancer       Date:  1970-06       Impact factor: 7.640
  5 in total
  4 in total

Review 1.  Immunocytoma o' mice an' men.

Authors:  J R Hobbs
Journal:  Br Med J       Date:  1971-04-10

Review 2.  Protein analyses in myelomatosis.

Authors:  P M Carter; L Slater; J Lee; D Perry; J R Hobbs
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1975

3.  The growth characteristics of an ascitic plasmacytoma (MP 5563) terminating by fistulous communication with the blood-stream.

Authors:  O Fakhri
Journal:  Br J Cancer       Date:  1970-06       Impact factor: 7.640

4.  Overcoming some limiting factors in tumour immunotherapy.

Authors:  O Fakhri; J R Hobbs
Journal:  Br J Cancer       Date:  1973-07       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.